Current Fellows' Research & Clinical Interests
(Preceptor and Preceptor’s Department or Division)
Oyebimpe Adesina, MD
Clinical fellow; will begin research in January 2014
Anosheh Afghahi, MD
Clinical fellow; will begin research in January 2014
Gregory Behbehani, MD, PhD (Garry Nolan, Microbiology and Immunology)
Proteomic analysis of signaling pathways in leukemic blasts
Steven Chan, MD, PhD (Ravindra Majeti, Hematology)
Discovery of Synthetic Lethal Interactions with Isocitrate Dehydrogenase (IDH) Mutations in Acute Myeloid Leukemia
Daniel Corey, MD
Clinical fellow; will begin research in July 2013
Monique de Bruin, MD, MPH (Allison Kurian, Oncology)
Clinical research in breast and ovarian cancer
Shira Dinner, MD (Michaela Liedtke, Hematology)
Pilot study of bortezomib, lenalidomide and dexamethasone in untreated and treated immunoglobulin light chain (AL) primary systemic amyloidosis
Tamara Dunn, MD (Michaela Liedtke, Hematology)
A phase I study of bortezomib in combination with pralatrexate in relapsed/refractory multiple myeloma
Maryliza El-Masry, MD
Clinical fellow; will begin research in January 2014
Jacqueline Suen Garcia, MD
Clinical fellow; will begin research in January 2013
Wan-Jen Hong, MD (Ravindra Majeti, Hematology)
Characterization of hematopoeitic stem cells in myeloproliferative neoplasms
Robert Wenchen Hsieh, MD, PhD
Clinical fellow; will begin research in March 2013
Brian Jonas, MD, PhD (Ravindra Majeti, Hematology)
Identification and characterization of leukemia stem cells in a mouse model of therapy-related acute myelogenous leukemia (AML)
Michael Khodadoust, MD, PhD
Clinical fellow; will begin research in January 2014
David Matthew Kurtz, MD
Clinical fellow; will begin research in January 2013
Anthony Lam, MD, MHS (H. Wakelee & S. Srinivas, Oncology; S. Schrier, Hematology)
Epidemiologic research in thoracic and urologic malignancies; Epidemiology of elderly anemia; Medtech innovations in hematology/oncology.
Aaron Logan, MD, PhD (Judy Shizuru, BMT)
Antibody-based conditioning for allo-transplant
James (Scott) McClellan, MD, PhD (Ravi Majeti, Hematology)
Investigating new therapeutic strategies for acute lymphoblastic leukemia
Everett Meyer, MD, PhD (Robert Negrin, BMT)
Study alloreactivity in bone marrow transplantation, specifically T cell dynamics in graft-versus-host disease in mouse models and human patients.
Siddhartha Mitra, MD, PhD
Clinical fellow; will begin research in January 2013
Rupa Narayan, MD
Clinical fellow; will begin research in January 2013
Sujata Narayanan, MD
Clinical fellow; will begin research in July 2013
David M. Nguyen, MD
Clinical fellow; will begin research in January 2014
Huong Thien (Marie) Nguyen, MD (Jason Gotlib, Hematology)
Evaluation of novel targeted therapies for patients with MPNs
Kim-Son Hoa Nguyen, MD, MPA
Clinical fellow; will begin research in January 2013
Sukhmani Kaur Padda, MD
Clinical fellow; will begin research in January 2013
Manali Patel, MD (Beverly Mitchell, Oncology)
Clinical trials in acute leukemia
Mary-Elizabeth Muchmore Percival, MD
Clinical fellow; will begin research in January 2013
Elie Richa, MD
Clinical fellow; will begin research in January 2014
Jonathan Riess, MD (Heather Wakelee, Oncology)
Clinical and translational research in
thoracic malignancies
Gabriel Rivera, MD
Clinical fellow; will begin research in January 2014
Jeffrey Russell, MD, PhD (Martin Brown, Radiation Oncology)
Radiation-induced vasculogenesis and the role of endothelial precursor cells as mediators of radiation and chemotherapy resistance
Somasundaram Subramaniam, MD (James Ford, Oncology)
Clinical GI oncology research
Alexander Ungewickell, MD, PhD (Paul Khavari, Dermatology)
Cutaneous T-cell lymphomas
Gregory Vidal, MD, PhD (Mark Pegram, Oncology)
Developmental therapeutics and early phase (1 and 11) clinical research project
Victor Villalobos, MD, PhD (Branimir Sikic, Oncology)
XL184 non randomized extension in ovarian cancer. FP1039 a FGF ligand trap in endometroid cancers.
Instructors' Research & Clinical Interests
Alice Fan, MD (Dean Felsher, Oncology)
Translational studies to validate the activity of targeted therapies using novel nanoscale technologies. Applying nanoscale proteomic analysis to clinical study of atorvastatin for lymphoma.
Lincoln Nadauld, MD, PhD (Calvin Kuo, Hematology)
Mouse models for gastric cancer
Shaveta Vinayak, MD (James Ford and Allison Kurian, Oncology)
Translational research in breast cancer
Yu Wong, MD, PhD (Mark Davis, Microbiology and Immunology)
Design of novel approach to measure T cell repertoire. Translational research in breast cancer